KINIKSA PHARMACEUTICALS INTE
KNSANASDAQ🏆 #1150 by market capEarnings Oct 26US Equity
$1,003.79▼ $49.59 (−4.94%)
Simulated price1h—
24h▼ 4.9%
7d—
14d—
30d—
1y—
🏦Market Cap
$6.07B
Small Cap
📈Revenue Growth (YoY)
+58.9%
High Growth
📊Gross Margin
89.8%
High
💵FCF Margin
21.7%
Strong
⚖️P/S Ratio
7.1x
Fair
Otter Score
45
Weak